Publications

Publications

1. Kim M, Kim JH, Park W, Park JC, Ahn JS, Kwun BD, Lee SG, Hwang S, Kim M, Lee S. Risk of Cerebral Aneurysm Rupture After Liver Transplantation: Development and Validation of a Hemorrhagic Stroke Scoring Model. J Korean Med Sci. 2024 Mar 11;39(9):e88. (IF 5.354)

 

2. Kim, J.H., Jeon, H., Kim, M., Lee S. Chemical and perfusion markers as predictors of moyamoya disease progression and complication types. Sci Rep 14, 56 (2024). (IF 4.6) Corresponding author

 

3. Kim JH, Choo YH, Kim M, Jeon H, Jung H-W, Ha EJ, Lee S Neurocritical Care Nutrition: Unique Considerations and Strategies for Optimizing Energy Supply and Metabolic Support in Critically Ill Patients. J Neurointensive Care. 2023;6(2):84-97. Corresponding author

 

4. Cha H, Choi JH, Jeon H, Kim JH, Kim M, Lee S. Aquaporin-4 Deficiency is Associated with Cognitive Impairment and Alterations in astrocyte-neuron Lactate Shuttle. Molecular Neurobiology. 2023;60(11):6212-26. (IF5.682) Corresponding author

 

5. Choo YH, Kim M, Kim JH, Jeon H, Jung H-W, Lee S. The Unique Relationship between Neuro-Critical Care and Critical Illness-Related Corticosteroid Insufficiency : Implications for Neurosurgeons in Neuro-Critical Care. J Korean Neurosurg Soc. 2023;66(6):618-31. (IF 1.6) Corresponding author

 

6. Shim Y, Kim J, Kim HS, Oh J, Lee S, Ha EJ.   Intracranial Pressure Monitoring for Acute Brain Injured Patients: When, How, What Should We Monitor.   Korean J Neurotrauma. 2023 Jun;19(2):149-161.

 

7. Jeong H, Kim JH, Choo YH, Kim M, Lee S, Ha EJ, Oh J.   Nutrition Therapy for Patients With Traumatic Brain Injury: A Narrative Review.   Korean J Neurotrauma. 2023 Jun;19(2):177-184

 

8. Kim JH, Jeong H, Choo YH, Kim M, Ha EJ, Oh J, Shim Y, Kim SB, Jung HG, Park SH, Kim JO, Kim J, Kim HS, Lee S.   Optimizing Mannitol Use in Managing Increased Intracranial Pressure: A Comprehensive Review of Recent Research and Clinical Experiences.   Korean J Neurotrauma. 2023 Jun;19(2):162-176 Corresponding author

 

9. Kim JH, Choo YH, Jeong H, Kim M, Ha EJ, Oh J, Lee S.   Recent Updates on Controversies in Decompressive Craniectomy and Cranioplasty: Physiological Effect, Indication, Complication, and Management.   Korean J Neurotrauma. 2023 Jun;19(2):128-148. Corresponding author

 

10.  Kim M, Jeon H, Chung Y, Lee SU, Park W, Park JC, Ahn JS, Lee S.   Efficacy of Acetylcysteine and Selenium in Aneurysmal Subarachnoid Hemorrhage Patients: A Prospective, Multicenter, Single Blind Randomized Controlled Trial.   J Korean Med Sci. 2023 May;38(21):e161 (IF 5.354) Corresponding author

 

11.  Choo YH, Kim JH, Jung HW, Kim M, Jeon H, Ha EJ, OH J, Shim Y, Kim SB, Jung HG, Park SH, Kim JO, Kim J, Kim H, Lee S Clinical Application and Significance of Indirect Calorimetry in Neurocritical Care. Journal of Neurointensive Care 2023; 6(1): 1-8. Corresponding author

 

12.  JEON H, Byun J, Kang H, Kim K, Lee E, Kim JH, Hong CK, Song SW, Kim Y-H, Chong SJ, Kim JH, Nam SJ, Park JE, Lee S. Proteomic analysis predicts anti-angiogenic resistance in glioblastoma. Journal of translational medicine , 2023 (IF 7.4) Corresponding author

 

13.  Rim HT, Ahn JS, Park JC, Byun J, Lee S, Park W. The risk factors of postoperative infarction after surgical clipping of unruptured anterior communicating artery aneurysms: anatomical consideration and infarction territory. Acta Neurochir (Wien). 2023 (IF 2.4)

 

14.  Kim M, Hong SK, Jeon SR, Roh SW, Lee S. Treatment Outcome and Risk Factors Associated with Diffuse Axonal Injury in Patients with Moderate to Severe Head Injury. Turk Neurosurg. 2022;32(1):6-15. (IF0.972) Corresponding author

 

15.  Byun J, Kim JH, Kim M, Lee S, Kim YH, Hong CK, Kim JH. Survival Outcomes and Predictors for Recurrence of Surgically Treated Brain Metastasis From Non-Small Cell Lung Cancer. Brain Tumor Res Treat. 2022 Jul;10(3):172-182.

 

16.  Yoon BH, Byun J, Kim M, Lee S, Park JC, Ahn JS, Park W. The influence of neurological disorders before cardiac myxoma surgery on the rate of postoperative recurrences: Analysis of 317 patients in a single center. World neurosurgery. 2021 (IF 2.0) Corresponding author

 

17.  Jeon H, Kim M, Park W, Lim JS, Lee E, Cha H, Ahn JS, Kim JH, Hong SH, Park JE, Lee EJ, Woo CW, Lee S. Upregulation of AQP4 Improves Blood-Brain Barrier Integrity and Perihematomal Edema Following Intracerebral Hemorrhage. Neurotherapeutics. 2021 Sep 20. (IF 5.7) Corresponding author

 

18.  Chung Y, Lee S, Park JC, Ahn JS, Moon EJ, Park JW, Park W. Prevalence of cerebrovascular diseases that can cause hemorrhagic stroke in liver transplantation recipients: a 6-year comparative study with 24,681 healthy adults. Neurol Sci. 2021 Jul;42(7):2753-2761. (IF 3.3)

 

19.  Kim M, Kim M, Lee S. Clinical case of cns-involved refractory thrombotic thrombocytopenic purpura. J Neurointensive Care. 2021;4:36-41 Corresponding author

 

20.  Kim M, Cho S, You SH, Park J, Park W, Park JC, Ahn JS, Kim M, Lee S. A prognostic model of pontine hemorrhage based on hemorrhage volume and location. J Neurointensive Care. 2021;4:21-29 Corresponding author

 

21.  Kim DA, Park SJ, Lee JY, Kim JH, Lee S, Lee E, Jang IY, Jung HW, Park JH, Kim BJ. Effect of CCL11 on In Vitro Myogenesis and Its Clinical Relevance for Sarcopenia in Older Adults. Endocrinol Metab (Seoul). 2021 Apr;36(2):455-465. (IF 3.4)

 

22.  Jung HW, Park JH, Kim DA, Jang IY, Park SJ, Lee JY, Lee S, Kim JH, Yi HS, Lee E, Kim BJ. Association between serum FGF21 level and sarcopenia in older adults. Bone. 2021 Apr;145:115877. (IF 4.1)

 

23.  Kim M, Byun J, Chung Y, Lee SU, Park JE, Park W, Park JC, Ahn JS, Lee S. Reactive Oxygen Species Scavenger in Acute Intracerebral Hemorrhage Patients. Stroke. 2021 Apr;52(4):1172-1181. (IF 10.17)  Corresponding author

 

24.  Park SY, Kim HC, Wee S, Kim YJ, Lim C-M, Kim Y-G, Lee GD, Lee S, Hwang HS, Jang SJ, Lee BH and Cho W-K. Case of a 21-Year-Old Man With Hemoptysis, Recurrent Pneumothorax, and Cavitary Lung Lesions. Chest. 2021;159:e13-e17. (IF 10.1)

 

25.  Yang JM, Park CS, Kim SH, Noh TW, Kim JH, Park S, Lee J, Park JR, Yoo D, Jung HH, Takase H, Shima DT, Schwaninger M, Lee S, Kim IK, Lee J, Ji YS, Jon S, Oh WY, Kim P, Uemura A, Ju YS and Kim I. Dll4 Suppresses Transcytosis for Arterial Blood-Retinal Barrier Homeostasis. Circ Res. 2020;126:767-783. (IF 23.218)

 

26.  Shin DW, Lee S, Song SW, Cho YH, Hong SH, Kim JH, Kim HS, Park JE, Nam SJ and Kim YH. Survival outcome and prognostic factors in anaplastic oligodendroglioma: a single-institution study of 95 cases. Sci Rep. 2020;10:20162. (IF 4.6)

 

27.  Kim M, Jeon S, Roh S. Hong S and Lee S. Treatment outcome and risk factors associated with diffuse axonal injury in patients with moderate to severe head injury. Turkish Neurosurgery. 2020. (IF 0.972) Corresponding author

 

28.  Kim M, Park W, Chung Y, Lee SU, Park JC, Kwon DH, Ahn JS and Lee S. Development and validation of a risk scoring model for postoperative adult moyamoya3 disease. Journal of neurosurgery. 2020:1-10. (IF 4.1) Corresponding author

 

29.  Kim M, Lee S, Park JC, Jang DM, Ha SI, Kim JU, Ahn JS and Park W. Anaphylactic Shock After Indocyanine Green Video Angiography During Cerebrovascular Surgery. World neurosurgery. 2020;133:74-79. (IF 2.0)

 

30.  Kim J, Jeong JH, Jung J, Jeon H, Lee S, Lim JS, Go H, Oh JS, Kim YG, Lee CK, Yoo B and Hong S. Immunological characteristics and possible pathogenic role of urinary CD11c+ macrophages in lupus nephritis. Rheumatology (Oxford). 2020;59:2135-2145. (IF 5.5)

 

31.  Jang IY, Park JH, Kim JH, Lee S, Lee E, Lee JY, Park SJ, Kim DA, Hamrick MW and Kim BJ. The association of circulating kynurenine, a tryptophan metabolite, with frailty in older adults. Aging (Albany NY). 2020;12:22253-22265. (IF 5.955)

 

32.  Jang IY, Lee S, Kim JH, Lee E, Lee JY, Park SJ, Kim DA, Hamrick MW, Park JH and Kim BJ. Lack of association between circulating apelin level and frailty-related functional parameters in older adults: a cross-sectional study. BMC Geriatr. 2020;20:420. (IF 4.1) Co-first author

 

33.  Jang IY, Jung HW, Park JH, Kim JH, Lee S, Lee E, Lee JY, Park SJ, Kim DA, Kim SJ, Yoo HJ and Kim BJ. Lower Serum n-3 Fatty Acid Level in Older Adults with Sarcopenia. Nutrients. 2020;12. (IF 5.9)

 

34.  Chung Y, Lee S, Park JC, Ahn JS, Moon EJ, Park JW and Park W. Prevalence of cerebrovascular diseases that can cause hemorrhagic stroke in liver transplantation recipients: a 6-year comparative study with 24,681 healthy adults. Neurol Sci. 2020. (IF 3.3)

 

35.  Chung J, Lee S, Park JC, Ahn JS and Park W. Scalp thickness as a predictor of wound complications after cerebral revascularization using the superficial temporal artery: a risk factor analysis. Acta Neurochir (Wien). 2020;162:2557-2563. (IF 2.4)

 

36.  Lee HS, Ahn JS, Park JC, Lee S, Kim M and Park W. Dominance of the Anterior Cerebral Artery as a Predictor of Vasospasm-Related Cerebral Infarction After Surgical Treatment of Ruptured Blood Blister-Like Aneurysm in the Internal Carotid Artery. World neurosurgery. 2019;130:e513-e524. (IF 2.0)

 

37.  Kim M, Lee HS, Lee S, Park JC, Ahn JS, Kwon DH, Kwun BD and Park W. Pediatric Intracranial Aneurysms: Favorable Outcomes Despite Rareness and Complexity. World neurosurgery. 2019;125:e1203-e1216. (IF 2.0)

 

38.  Hong SP, Song S, Lee S, Jo H, Kim HK, Han J, Park JH and Cho SW. Regenerative potential of mouse embryonic stem cell-derived PDGFRα(+) cardiac lineage committed cells in infarcted myocardium. World J Stem Cells. 2019;11:44-54. (IF 5.247)

 

39.  Park W, Park ES, Lee S, Park JC, Chung J, Lee JM and Ahn JS. Intracranial Hemorrhage After Superficial Temporal Artery-Middle Cerebral Artery Direct Anastomosis for Adults with Moyamoya Disease. World neurosurgery. 2018;119:e774-e782. (IF 2.0)

 

40.  Park W, Ahn JS, Chung J, Chung Y, Lee S, Park JC and Kwun BD. Neurologic Deterioration in Patients with Moyamoya Disease during Pregnancy, Delivery, and Puerperium. World neurosurgery. 2018;111:e7-e17. (IF 2.0)

 

41.  Lee HS, Kim JH, Kim YH and Lee S. Surgically Treated Community-Acquired Brain Abscess: Bacteriological Analysis Based on Predisposing Infections. Jpn J Infect Dis. 2018;71:191-196. (IF 2.2) Corresponding author

 

42.  Lee HS, Kim JH, Kim YH and Lee S. Predictors of unprovoked seizures in surgically treated pyogenic brain abscess: Does perioperative adjunctive use of steroids has any protective effect? Clin Neurol Neurosurg. 2018;173:46-51. (IF 1.9) Corresponding author

 

43.  Kim M, Hong SK, Jeon SR, Roh SW and Lee S. Early (≤48 Hours) versus Late (>48 Hours) Surgery in Spinal Cord Injury: Treatment Outcomes and Risk Factors for Spinal Cord Injury. World neurosurgery. 2018;118:e513-e525. (IF 2.0) Corresponding author

 

44.  Kim M, Ahn JS, Park W, Hong SK, Jeon SR, Roh SW and Lee S. Diffuse axonal injury (DAI) in moderate to severe head injured patients: Pure DAI vs. non-pure DAI. Clin Neurol Neurosurg. 2018;171:116-123. (IF 1.9) Corresponding author

 

45.  Kim IK, Kim K, Lee E, Oh DS, Park CS, Park S, Yang JM, Kim JH, Kim HS, Shima DT, Kim JH, Hong SH, Cho YH, Kim YH, Park JB, Koh GY, Ju YS, Lee HK, Lee S and Kim I. Sox7 promotes high-grade glioma by increasing VEGFR2-mediated vascular abnormality. J Exp Med. 2018;215:963-983. (IF 15.3) Co-Corresponding author

 

46.  Jeon SB, Park JC, Kwon SU, Kim YJ, Lee S, Kang DW and Kim JS. Intracranial Pressure Soon After Hemicraniectomy in Malignant Middle Cerebral Artery Infarction. J Intensive Care Med. 2018;33:310-316. (IF 3.1)

 

47.  Byun J, Park ES, Hong SH, Cho YH, Kim YH, Kim CJ, Kim JH and Lee S. Clinical outcomes of primary intracranial malignant melanoma and metastatic intracranial malignant melanoma. Clin Neurol Neurosurg. 2018;164:32-38. (IF 1.9) Corresponding author

 

48.  Byun J, Ahn JS, Park W, Hong SH, Kim Y-H, Kim CJ, Kim JH and Lee S. Microsurgical treatment outcomes of brainstem cavernous malformation: Subgroup comparison depending on application of intraoperative neurophysiologic monitoring. Interdisciplinary Neurosurgery. 2018;13:74-81. (IF 0.4) Corresponding author

 

49.  Park JS, Kim IK, Han S, Park I, Kim C, Bae J, Oh SJ, Lee S, Kim JH, Woo DC, He Y, Augustin HG, Kim I, Lee D and Koh GY. Normalization of Tumor Vessels by Tie2 Activation and Ang2 Inhibition Enhances Drug Delivery and Produces a Favorable Tumor Microenvironment. Cancer cell. 2017;31:157-158. (IF 50.3)

 

50.  Lee S, Choi JH, Kim CJ and Kim JH. Clinical Interrogation for Unveiling an Isolated Hypophysitis Mimicking Pituitary Adenoma. World neurosurgery. 2017;99:735-744. (IF 2.0) - First author

 

51.  Hong SP, Song S, Cho SW, Lee S, Koh BI, Bae H, Kim KH, Park JS, Do HS, Im I, Heo HJ, Ko TH, Park JH, Youm JB, Kim SJ, Kim I, Han J, Han YM and Koh GY. Generation of PDGFRα(+) Cardioblasts from Pluripotent Stem Cells. Sci Rep. 2017;7:41840. (IF 4.6)

 

52.  Park JS, Kim IK, Han S, Park I, Kim C, Bae J, Oh SJ, Lee S, Kim JH, Woo DC, He Y, Augustin HG, Kim I, Lee D and Koh GY. Normalization of Tumor Vessels by Tie2 Activation and Ang2 Inhibition Enhances Drug Delivery and Produces a Favorable Tumor Microenvironment. Cancer cell. 2016;30:953-967. (IF 50.3)

 

53.  Lee S, Kwon DH, Kim CJ and Kim JH. Long-term outcomes following Gamma Knife radiosurgery for small, newly diagnosed meningiomas. Clin Neurol Neurosurg. 2016;142:1-7. (IF 1.9) First author

 

54.  Lee S, Jun GW, Jeon SB, Kim CJ and Kim JH. Paroxysmal sympathetic hyperactivity in brainstem-compressing huge benign tumors: clinical experiences and literature review. Springerplus. 2016;5:340.

 

55.  Lee S, Hong SH, Cho YH, Kim JH and Kim CJ. Anatomical Origin of Tuberculum Sellae Meningioma: Off-Midline Location and Its Clinical Implications. World neurosurgery. 2016;89:552-61. (IF 2.0) First author

 

56.  Jeon SB, Kwon SU, Lee S ,Park JC, Lee DH, Yun SC, Kim YJ, Ahn JS, Kwun BD, Kang DW, Choi HA, Lee K and Kim JS. Reduction of Midline Shift Following Decompressive Hemicraniectomy for Malignant Middle Cerebral Artery Infarction. J Stroke. 2016;18:328-336. (IF 8.2)

 

57.  Han S, Lee SJ, Kim KE, Lee HS, Oh N, Park I, Ko E, Oh SJ, Lee YS, Kim D, Lee S, Lee DH, Lee KH, Chae SY, Lee JH, Kim SJ, Kim HC, Kim S, Kim SH, Kim C, Nakaoka Y, He Y, Augustin HG, Hu J, Song PH, Kim YI, Kim P, Kim I and Koh GY. Amelioration of sepsis by TIE2 activation-induced vascular protection. Science translational medicine. 2016;8:335ra55. (IF 17.1)

 

58.  Lee S, Kim IK, Ahn JS, Woo DC, Kim ST, Song S, Koh GY, Kim HS, Jeon BH and Kim I. Deficiency of endothelium-specific transcription factor Sox17 induces intracranial aneurysm. Circulation. 2015;131:995-1005. (IF 37.8) First author

 

59.  Yang H, Lee S, Lee S, Kim K, Yang Y, Kim JH, Adams RH, Wells JM, Morrison SJ, Koh GY and Kim I. Sox17 promotes tumor angiogenesis and destabilizes tumor vessels in mice. J Clin Invest. 2013;123:418-31. (IF 15.9)


Patent

1.교모세포종 환자의 혈관신생억제제에 대한 치료 반응성을 예측하는 방법 -2019.09

2.신경교종의 혈관신생억제제에 대한 반응성 예측 판단용 바이오 마커-대한민국-2018.11 

3.뇌압 측정 장치(INTRACRANIAL PRESSURE MEASUREMEN APPARATUS) -2017

4.뇌압측정시스템 -2016

BOOK

1.     Meningioma and Schwannoma, Practical Guidelines for Surgical Treatment. (Editors: Michael W. McDermott & HW Jung)

Chapter II. “Microsurgical management of tuberculum sellae meningioma”

2.     ICU guidebook. Chapter “Head & Spine trauma”

PRESENTATIONS & SEMINARS

PRESENTATIONS & SEMINARS

1.   The Second Pacific Symposium on Vascular Biology, Jeju, Korea, 2011.10

Poster presentation: “The role of Sox17 in tumor angiogenesis”

2.   The 18th International Vascular Biology Meeting, Kyoto, Japan, 2014.4

Poster presentation: The transcription factor Sox17 deficiency induces intracranial aneurysm”

3.   Asan Neurosurgical Seminar, 2014.5

Invited seminar: “Deficiency of Endothelial transcription factor Sox17 causes intracranial aneurysm”

4.   Biomedical statistics seminar in KAIST graduate School of Biomedical Science and Engineering, Daejeon, Korea, 20105.2

Invited seminar: “Brief Review of Biomedical Statistics”

5.   Up to date seminar in Yuhan Corporation, Yong-in, Korea, 2015.5

Invited seminar: “Cutting Edge in Biological Arsenals against Tumor Angiogenesis” 

6.   The 14th Asian Australasian Congress of Neurological Surgery, Jeju, Korea, 2015.4

Oral presentation: “The proangiogenic transcription factor Sox17 induces tumor angiogenesis” 

7.   2018 Annual Meeting of the Korean Society for Vascular Biology and Medicine & KVBM-IBS Joint Symposium. October 10~12, 2018 KAIST, Daejeon Young Scientist in Vascular Biology Title: Vascular Characteristics of Mouse Glioblastoma Model: Orthotopic versus Spontaneous Model

8.   2019. ASAN-KAIST symposium, December 11, 2019, Seoul, Korea. Aquaporin 4 deficiency-induced blood-brain barrier disruption caused perihematomal edema in hemorrhagic stroke

9.   The 3rd Neurological Emergency Team Symposium, October 30, 2021, The Blood-Brain Barrier: Science and Surgery

10.The 4th Neurological Emergency Team Symposium, November, 26, 2022, In-Hospital Emergencies: Neurosurgical Perspectives

11.2023 41th Annual Meeting of the Korean Neurosurgical Society, March 30-April 1, 2023, Jeju, Korea.Oral presentation “ Immunological environment determines the therapeutic response to concurrent chemoradiation glioblastoma & Management of status epilepticus in neurosurgical ICU